DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Information source: Eli Lilly and Company
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Osteoporosis, Postmenopausal

Intervention: teriparatide (Drug); raloxifene (Drug); placebo (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Eli Lilly and Company

Summary

The purpose of this study is to compare treatment with both teriparatide and raloxifene with teriparatide alone. The study will evaluate any side effects that may be associated with the two drugs and may help to determine whether teriparatide and raloxifene together can help patients with osteoporosis more than teriparatide alone.

Clinical Details

Study design: Primary Purpose: Treatment

Eligibility

Minimum age: 45 Years. Maximum age: 85 Years. Gender(s): Female.

Criteria:

Inclusion Criteria

- Must be diagnosed with osteoporosis.

- Must be female, age 45 through 85.

- Must be at least 5 years postmenopausal.

- Must be free of other severe or chronically disabling conditions.

- Must be able to properly use injection device.

Exclusion Criteria

- Must not have bone diseases other than osteoporosis.

- Must not have history of certain cancers.

- Must not have certain medical diseases (inflammatory bowel disease, malabsorption

syndrome, kidney or bladder stones, venous thrombi or emboli, recent vaginal bleeding due to unknown causes).

- Must not have taken or are currently taking certain types of medicines.

- Must not have known allergy to the study agent or SERM.

Locations and Contacts

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Anaheim, California 92801, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Oakland, California 94612, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Altamonte Springs, Florida 32714, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Chicago, Illinois 60622, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Cedar Rapids, Iowa 52401, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Baltimore, Maryland 21204, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Hagerstown, Maryland 21740, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Voorhees, New Jersey 08043, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Cleveland, Ohio 44195, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Oklahoma City, Oklahoma 73109, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Portland, Oregon 97213, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Duncansville, Pennsylvania 16635, United States

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Dallas, Texas 75231, United States

Additional Information


Last updated: July 19, 2006

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017